![Mark Paulik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Mark Paulik first degree
Entity | Entity type | Industry | |
---|---|---|---|
Phoundry Pharmaceuticals, Inc.
![]() Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Phoundry Pharmaceuticals, Inc. engages in the discovery of peptide therapeutic drugs for metabolic diseases. The firm also provides drugs for diabetes and obesity diseases. The company was founded by Paul L. Feldman, Andrew Young, Ved Srivastava, Mark Paulik, James Way and Shane Roller in 2015 and is headquartered in Research Triangle Park, NC.
5
| Subsidiary | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mark Paulik via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Lucknow | College/University | Doctorate Degree | |
Psylin Neurosciences, Inc.
![]() Psylin Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Psylin Neurosciences, Inc. discovers and develops peptide hormones for the treatment of psychiatric disorders. The firm is formed in partnership between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. The company was founded on January 30, 2007 and is located in San Diego, CA | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Peptide Society, Inc.
![]() American Peptide Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Peptide Society, Inc. operates as scientific and educational organization which provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. The company was founded in 1990 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | President | |
Auckland University | College/University | Corporate Officer/Principal | |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Chief Tech/Sci/R&D Officer | |
Satiogen Pharmaceuticals, Inc.
![]() Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Miscellaneous Commercial Services | Founder |
Statistics
International
United States | 7 |
India | 2 |
New Zealand | 2 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 3 |
Process Industries | 2 |
Government | 2 |
Operational
Founder | 6 |
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 2 |
Director/Board Member | 2 |
Most connected contacts
Insiders | |
---|---|
Ved Srivastava | 6 |
Andrew Young | 5 |
Paul L. Feldman | 1 |
Shane Roller | 1 |
James Way | 1 |
- Stock Market
- Insiders
- Mark Paulik
- Company connections